Skip to content

Biomarker assessment in adults with thoracic aortic aneurysm or dissection

Biomarker assessment in adults with thoracic aortic aneurysm or dissection - BioTAAD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45356
Enrollment
400
Registered
2018-01-11
Start date
2017-09-04
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic aortic aneurysm thoracic aortic dilatation

Interventions

Anxiety
Biomarker
Depression
Thoracic aortic aneurysm
Thoracic aortic dissection

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Scheduled for an appointment at the outpatient department for thoracic aorta disease in the Erasmus MC - Thoracic aorta pathology with or without known genetic mutation - Receiving imaging of the aorta with use of echocardiography or computer tomography (CT) - Capable of understanding and signing informed consent.

Exclusion criteria

Exclusion criteria: - Patients who are not capable of understanding and signing informed consent. - Age

Design outcomes

Primary

MeasureTime frame
The main study parameter will be increase in dimension of the aorta.

Secondary

MeasureTime frame
Secondary study parameters/endpoints are mortality, need for interventions and complications (aortic dissection). Also the incidence of anxiety/depression and the quality of life of patients and partners or family members will be secondary endpoints.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)